Clinical Trials on Hyperphosphatemic

Total 204 results

Fresenius Medical Care Deutschland GmbH
Siro Clinpharm Germany GmbH

Completed

Non-interventional Study to Evaluate the Ease of Reaching Individual Goals in Serum Phosphorus (Steering) (Steering)

ESRD | Hyperphosphataemia

United Kingdom, Spain, Denmark, Germany
Phosphate Therapeutics
Clinipace Worldwide

Completed

Study to Evaluate the Efficacy and Safety of PT20 in Subjects With Hyperphosphataemia and Dialysis Dependent Chronic Kidney Disease

Hyperphosphataemia
Genzyme, a Sanofi Company

Completed

Post Authorisation Safety Study of Renvela® in Chronic Kidney Disease Patients Not on Dialysis With Hyperphosphataemia

Chronic Kidney Disease | Hyperphosphataemia

France, Germany, Spain, Netherlands, Italy, Austria, Denmark
Amgen

Completed

Study to Assess Fixed Dosing of AMG 223 in Subjects With Chronic Kidney Disease on Hemodialysis With Hyperphosphatemia

End Stage Renal Disease | Chronic Kidney Disease | Kidney Disease | Hyperphosphatemic
Haukeland University Hospital

Unknown

Hypophosphatemic Rickets in Norway

Hyperphosphatemia | Rickets | Hypophosphatemia, Familial

Norway
Taisho Pharmaceutical Co., Ltd.

Completed

A Phase 2 Dose-finding Study of TS-172 in Hyperphosphatemia Patients on Hemodialysis

Hyperphosphatemia Patients on Hemodialysis

Japan
Kissei Pharmaceutical Co., Ltd.

Completed

A Long-term Study of PA21 in Hemodialysis Patients With Hyperphosphatemia

Hemodialysis Patients With Hyperphosphatemia

Japan
Astellas Pharma Inc

Completed

Post-marketing Surveillance of Kiklin Capsules in Hemodialysis Patients

Chronic Renal Failure Patients With Hyperphosphataemia Receiving Hemodialysis

Japan
Kyowa Kirin Korea Co., Ltd.

Recruiting

Post Marketing Surveillance Study to Observe Safety and Effectiveness of NEPHOXIL ® in S. Korea Patients

Hyperphosphatemia

Korea, Republic of
Kyowa Kirin Co., Ltd.

Completed

A Phosphate Binder Switch Study of KHK7791 in Hyperphosphatemia Patients on HD

Hyperphosphatemia

Japan
Kyowa Kirin Co., Ltd.

Completed

Phosphate Binder Switch Study of KHK7791 in Hyperphosphatemia Patients on Hemodialysis

Hyperphosphatemia

Japan
Bayer

Completed

Fosrenol Post-marketing Surveillance for Continuous Cyclic Peritoneal Dialysis in Japan (FOSRENOL-CAPD)

Hyperphosphatemia

Japan
Bayer

Completed

Bioequivalence Study of BAY77-1931 Granule

Hyperphosphatemia

Japan
Washington University School of Medicine

Completed

The Effect of Oral Niacinamide on Plasma Phosphorus Levels in Peritoneal Dialysis Patients

Hyperphosphatemia

United States
Fresenius Medical Care North America
Renal Research Institute

Completed

Phosphate Kinetic Modeling 2 (PKM2)

ESRD | Hyperphosphatemia

United States
Bayer

Completed

Long-term Treatment on BAY77-1931 (Lanthanum Carbonate) to Measure Lanthanum Concentrations in Bone

Hyperphosphatemia | Dialysis

Japan
Grand Life Science (Liaoning) Co., Ltd.
The First Hospital of Jilin University

Recruiting

To Evaluate the Patient Tolerance, Pharmacodynamics and Pharmacokinetics of Lanthanum Polystyrene Sulfonate Powder

Hyperphosphatemia

China
Kyowa Kirin Co., Ltd.

Completed

Phosphate Binder-combination Study of KHK7791 in Hyperphosphatemia Patients

Hyperphosphatemia

Japan
Kyowa Kirin Co., Ltd.

Completed

Clinical Study of KHK7791 in Hyperphosphatemia Patients on Peritoneal Dialysis

Hyperphosphatemia

Japan
Kyowa Kirin Co., Ltd.

Completed

Clinical Study of KHK7791 in Hyperphosphatemia Patients on Hemodialysis

Hyperphosphatemia

Japan
RWTH Aachen University

Terminated

Velphoro and Impact on the Oral Cavity and Gut Microbiome (MicrobiomEisen)

Hyperphosphatemia

Germany
MetroHealth Medical Center

Completed

Phosphorus Improvement Pilot Study

Hyperphosphatemia
Yale University
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

Completed

Calcitonin for Treating X-linked Hypophosphatemia

Hypophosphatemic Rickets, X Linked Dominant

United States
Bicetre Hospital

Completed

Growth Hormone Treatment in Children With Hypophosphatemic Rickets (GH-XLH)

X Linked Hypophosphatemic Rickets
Kissei Pharmaceutical Co., Ltd.

Completed

A Phase III Study of PA21 in Hemodialysis Patients With Hyperphosphatemia

Hemodialysis | Hyperphosphatemia

Japan
Kyowa Kirin Co., Ltd.

Completed

Dose-finding Study of KHK7791 in Hyperphosphatemia Patients

Hyperphosphatemia

Japan
Ardelyx

Completed

A Phase 3 Study of Tenapanor to Treat Hyperphosphatemia in ESRD Patients on Dialysis

Hyperphosphatemia

United States
Kaiser Permanente
Keryx Biopharmaceuticals

Completed

Transition to Ferric Citrate Among Hemodialysis and Peritoneal Dialysis Patients

Hyperphosphatemia

United States
Kyowa Kirin Co., Ltd.

Completed

Phosphate Binder-combination Study of KHK7791 in Hyperphosphatemia Patients on Hemodialysis

Hyperphosphatemia

Japan
Shire

Completed

Long-term Effect of Lanthanum Carbonate on Bone

Hyperphosphatemia

United States, Germany, United Kingdom
Bayer

Completed

Fosrenol Post-marketing Surveillance for Hemodialysis in Japan (FOSRENOL-HD)

Hyperphosphatemia

Japan
Vifor Fresenius Medical Care Renal Pharma

Completed

Non-interventional Study to Investigate the Short and Long Term Real-life Safety, Effectiveness, and Adherence of Velphoro® in Patients With Hyperphosphataemia Undergoing Haemodialysis (HD) or Peritoneal Dialysis (PD) (VERIFIE)

Hyperphosphatemia

Spain, Netherlands, Germany, Italy, France, Greece, United Kingdom
Jiujiang No.1 People's Hospital

Unknown

Nicotinic Acid in Hemodialysis Patients With Hyperphosphatemia (NAHPH)

Hyperphosphatemia

China
Shiraz University of Medical Sciences

Completed

The Effect of Magnesium Oxide on Plasma Phosphate in Hemodialysis Patients

Hyperphosphatemia

Iran, Islamic Republic of
Bayer

Completed

BAY 77-1931 Long-term Extension From Phase II Study

Hyperphosphatemia

Japan
Shanghai Jiao Tong University School of Medicine
Baxter Healthcare Corporation

Unknown

The Effect of Systemic Dietary Instruction on Management of Plasma Phosphorus Levels in Peritoneal Dialysis (PD) Patients

Hyperphosphatemia

China
Taipei Medical University WanFang Hospital

Unknown

The Influence of Dietary Phosphorus Education Program on Nutritional Status and Serum Phosphate Level Among Hemodialysis Patient

Malnutrition | Hyperphosphatemia

Taiwan
Romanian Society of Nephrology

Withdrawn

Arterial Stiffness and Calcifications in Haemodialysis Patients on Sevelamer or Calcium Acetate

Hyperphosphatemia | Haemodialyzed Patients

Romania
Astellas Pharma Inc

Completed

Single and Multiple Dosing Study in Hemodialysis Patients With Hyperphosphatemia in Japan

Chronic Kidney Disease | Hyperphosphatemia Undergoing Hemodialysis

Japan
Kissei Pharmaceutical Co., Ltd.

Completed

A Phase III Study of PA21 With Calcium Carbonate in Hemodialysis Patients With Hyperphosphatemia

Hemodialysis | Hyperphosphatemia

Japan
Kyowa Kirin Co., Ltd.

Completed

A Study of KRN23 in Pediatric Patients With X-linked Hypophosphatemic Rickets/Osteomalacia

X-linked Hypophosphatemic Rickets/Osteomalacia

Japan
Kyowa Kirin Co., Ltd.

Completed

A Study of KRN23 in Subjects With X-linked Hypophosphatemic Rickets/Osteomalacia

X-linked Hypophosphatemic Rickets/Osteomalacia

Japan, Korea, Republic of
University College Cork
Cork University Hospital; Irish Nutrition & Dietetic Institute

Completed

Decreasing Intakes & Absorption of Phosphorus in Haemodialysis Patients Through Food Choices (DIP HD)

Hyperphosphatemia | Dietary Modification | Renal Dialysis

Ireland
University of Illinois at Chicago
Shire

Completed

Efficacy of Phosphate Binding in Healthy Volunteers: Chewed Versus Crushed Lanthanum Carbonate

Hyperphosphatemia in Chronic Kidney Disease

United States
Hospital Universitari de Bellvitge
Vifor Pharma

Active, not recruiting

mHealth for Phosphorus Management in CKD. (PHOSFO_OK)

Dialysis Related Complication

Spain
Chugai Pharma Taiwan

Completed

Long Term Evaluation of Sevelamer HCl vs. Calcium-based Phosphate Binder in the Treatment of Hyperphosphatemia in Hemodialysis Patients

Hemodialysis | Hyperphosphatemia | Cardiovascular Events
Chen Jing
Shanghai Tongji Hospital, Tongji University School of Medicine; Huadong Hospital

Completed

Individualized Treatment of Hyperphosphatemia in Maintenance Hemodialysis Patients

Hyperphosphatemia | Maintenance Hemodialysis

China
Daiichi Sankyo, Inc.

Completed

DS2330b Alone and With Sevelamer in Patients on Chronic Hemodialysis

Hyperphosphatemia

United States
Kissei Pharmaceutical Co., Ltd.

Completed

A Phase III Study of PA21 in Peritoneal Dialysis Patients With Hyperphosphatemia

Peritoneal Dialysis | Hyperphosphatemia

Japan
Fresenius Medical Care North America

Completed

Bioequivalence Study Comparing Calcium Acetate Oral Solution Versus Calcium Acetate Gelcaps in Healthy Volunteers

Hyperphosphatemia

United States

Clinical Trials on Hyperphosphatemic

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Argentina

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations